Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$42.5B |
| 2 |
NVIDIA
NVDA
|
+$2.39B |
| 3 |
Walmart Inc
WMT
|
+$1.17B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 5 |
JPMorgan Chase
JPM
|
+$808M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.26B |
| 2 |
Amazon
AMZN
|
+$843M |
| 3 |
Xcel Energy
XEL
|
+$674M |
| 4 |
Global Payments
GPN
|
+$623M |
| 5 |
Palantir
PLTR
|
+$577M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.11% |
| 2 | Financials | 7.1% |
| 3 | Communication Services | 5.53% |
| 4 | Consumer Discretionary | 5.34% |
| 5 | Healthcare | 4.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2951
Zumiez
ZUMZ
$347M
| $691K | ﹤0.01% |
31,198
-20,438
| -40% | -$498K |
|
2952
Cellebrite
CLBT
$3.7B
| $690K | ﹤0.01% |
50,098
+43,793
| +695% | +$660K |
|
|
GDEN
2953
DELISTED
Golden Entertainment
GDEN
| $690K | ﹤0.01% |
25,836
-20,419
| -44% | -$566K |
|
2954
Ardagh Metal Packaging
AMBP
$3.11B
| $687K | ﹤0.01% |
169,680
-1,614,355
| -90% | -$7.16M |
|
|
CLDT
2955
Chatham Lodging
CLDT
$638M
| $687K | ﹤0.01% |
87,308
-65,703
| -43% | -$489K |
|
2956
Build-A-Bear
BBW
$443M
| $687K | ﹤0.01% |
18,346
-1,034
| -5% | -$54.5K |
|
2957
Unitil
UTL
$1.01B
| $687K | ﹤0.01% |
13,150
-22,820
| -63% | -$1.17M |
|
2958
Baytex Energy
BTE
$2.86B
| $687K | ﹤0.01% |
153,667
+71,813
| +88% | +$265K |
|
2959
Replimune Group
REPL
$449M
| $686K | ﹤0.01% |
89,622
-202,563
| -69% | -$1.55M |
|
2960
Radiant Logistics
RLGT
$411M
| $685K | ﹤0.01% |
97,203
-49,588
| -34% | -$348K |
|
2961
Twin Disc
TWIN
$333M
| $684K | ﹤0.01% |
45,420
+30,968
| +214% | +$523K |
|
2962
Arcutis Biotherapeutics
ARQT
$3.55B
| $682K | ﹤0.01% |
28,965
-302,613
| -91% | -$7.72M |
|
2963
Fulcrum Therapeutics
FULC
$248M
| $678K | ﹤0.01% |
88,458
-44,083
| -33% | -$409K |
|
2964
Tredegar Corp
TG
$263M
| $678K | ﹤0.01% |
85,256
-37,552
| -31% | -$314K |
|
|
VOYG
2965
Voyager Technologies
VOYG
$1.52B
| $677K | ﹤0.01% |
28,946
-5,104
| -15% | -$147K |
|
2966
ARS Pharmaceuticals
SPRY
$563M
| $676K | ﹤0.01% |
84,169
-112,218
| -57% | -$1.08M |
|
2967
Bilibili
BILI
$7.56B
| $675K | ﹤0.01% |
29,903
-36,095
| -55% | -$1.04M |
|
|
AIFC
2968
AI Financial Corp
AIFC
$54.9M
| $674K | ﹤0.01% |
607,304
-76,657
| -11% | -$125K |
|
|
OPLN
2969
Openlane
OPLN
$4.27B
| $672K | ﹤0.01% |
23,051
-141,556
| -86% | -$4.09M |
|
2970
Blue Owl Capital
OBDC
$5.47B
| $671K | ﹤0.01% |
60,674
+9,464
| +18% | +$111K |
|
2971
CytomX Therapeutics
CTMX
$701M
| $669K | ﹤0.01% |
142,412
-194,113
| -58% | -$985K |
|
2972
Bausch Health
BHC
$1.69B
| $668K | ﹤0.01% |
123,783
+103,818
| +520% | +$621K |
|
|
KW
2973
DELISTED
Kennedy-Wilson Holdings
KW
| $667K | ﹤0.01% |
61,631
-139,796
| -69% | -$1.45M |
|
2974
Viemed Healthcare
VMD
$457M
| $666K | ﹤0.01% |
72,277
-59,482
| -45% | -$495K |
|
2975
Shutterstock
SSTK
$220M
| $666K | ﹤0.01% |
40,071
-37,843
| -49% | -$666K |
|
Similar funds
Barclays's Q1 2026 Portfolio in Review
As of Q1 2026, Barclays held 5,572 positions worth $416B, down 0.11% from $417B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Barclays deployed $19.3B of net new capital in Q1 2026, opening 398 new positions and adding to 1,219 existing holdings. Its largest new stake was Sunbelt Rentals Holdings: 1,528,635 shares worth $99.5M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 20% a quarter earlier, followed by Financials and Communication Services.
On the sell side, the largest reduction was Tesla, an estimated $1.26B trimmed.
- Barclays's largest Q1 2026 buy was Sunbelt Rentals Holdings: 1,528,635 shares worth $99.5M.
- Barclays added most to iShares MSCI Emerging Markets ETF in Q1 2026, an estimated $42.5B increase.
- Barclays's biggest Q1 2026 reduction was Tesla, cutting an estimated $1.26B.
- Barclays fully exited CyberArk in Q1 2026, selling an estimated $232M.
- Barclays's ten largest holdings make up 37% of its $416B portfolio in Q1 2026.
- Barclays opened 398 new positions and closed 564 in Q1 2026.
- Barclays's portfolio value fell 0.11% quarter-over-quarter to $416B.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.